Search results
FDA greenlights CEL-SCI confirmatory study for Multikine By Investing.com
Investing.com· 1 day agoCEL-SCI Corporation (NYSE American: CVM) announced today that the U.S. Food and Drug Administration...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 1 day agoThat RS Rating means Pfizer stock ranks in the bottom 18% of all stocks in terms of performance over...
Biotech CEL-SCI gets FDA go-ahead to conduct investigational cancer immunotherapy study - Maryland...
The Daily Record· 1 day agoThe FDA agreed to a 212-person confirmatory Registration Study based on the strength of the safety and survival benefit data in the selected target population from the prior ...
The Quest for Treatments to Keep Weight Off After Ozempic
The Wall Street Journal· 2 days agoAida Diaz sat down at a long table laden with fried chicken, french fries, salad and more. Pick what...
The 3 Best Bargain Stocks to Buy in May 2024
InvestorPlace· 12 hours agoThere are several types of bargain stocks available to buy in the stock market. There are, of course, traditional bargain stocks with very low valuations...
Combination Therapy Holds Promise for Pancreatic Cancer Treatment: A Milestone Collaboration Between...
NewMediaWire via Yahoo Finance· 8 hours agoFREMONT, CA - (NewMediaWire) - May 09, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a...
3 Michael Burry Stocks Set to Double Your Money by 2027
InvestorPlace· 2 days agoThe ultimate goal of investing is to find possibilities poised for significant development. Michael...
Automation supplier plots new HQ in Southeast Michigan
Automotive News· 5 hours agoConvergix, which plans to take the 150,100-square-foot space in August, is riding high on the demand for automation in the automotive industry as OEMs and suppliers lean harder into robots to ...
Sentynl Therapeutics Announces Global Acquisition of Zokinvy® (Lonafarnib) for Treatment of...
KTLA-TV Los Angeles· 6 days agoSentynl, a Zydus Group company, receives worldwide proprietary rights to Zokinvy, adding to portfolio of biopharmaceuticals for rare and ultra-rare diseases Zokinvy is approved ...
Restaurant groups blast latest details on state's junk fees law - San Francisco Business Times
The Business Journals· 24 hours agoNew official guidance released by California Attorney General Rob Bonta's office on SB478 — the...
